Takara Cash from 2010 to 2026

TF2 Stock  EUR 6.10  0.25  4.27%   
Takara Bio's Cash is increasing over the last several years with slightly volatile swings. Cash is predicted to flatten to about 25.7 B. Cash is the total amount of money in the form of currency that Takara Bio has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2016-12-31
Previous Quarter
29.5 B
Current Value
21 B
Quarterly Volatility
9.5 B
 
Covid
 
Interest Hikes
Check Takara Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Takara Bio's main balance sheet or income statement drivers, such as Interest Expense of 24.1 M, Selling General Administrative of 601.1 M or Total Revenue of 45.1 B, as well as many indicators such as . Takara financial statements analysis is a perfect complement when working with Takara Bio Valuation or Volatility modules.
  
This module can also supplement various Takara Bio Technical models . Check out the analysis of Takara Bio Correlation against competitors.
The Cash trend for Takara Bio offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Takara Bio is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Takara Bio's Cash Growth Pattern

Below is the plot of the Cash of Takara Bio over the last few years. Cash refers to the most liquid asset of Takara Bio, which is listed under current asset account on Takara Bio balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Takara Bio customers. The amounts must be unrestricted with restricted cash listed in a different Takara Bio account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Takara Bio's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Takara Bio's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Takara Cash Regression Statistics

Arithmetic Mean21,129,220,098
Geometric Mean17,234,652,277
Coefficient Of Variation60.16
Mean Deviation10,017,880,104
Median19,384,000,000
Standard Deviation12,712,173,300
Sample Variance161599350T
Range45.4B
R-Value0.80
Mean Square Error62776366.2T
R-Squared0.64
Significance0.0001
Slope2,007,305,351
Total Sum of Squares2585589600.1T

Takara Cash History

202625.7 B
202534 B
202429.5 B
202335.4 B
202251.8 B
202123.6 B
202026 B

About Takara Bio Financial Statements

Takara Bio stakeholders use historical fundamental indicators, such as Takara Bio's Cash, to determine how well the company is positioned to perform in the future. Although Takara Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Takara Bio's assets and liabilities are reflected in the revenues and expenses on Takara Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Takara Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash34 B25.7 B
Change In Cash-5.5 B-5.2 B
Total Cashflows From Investing Activities-8.1 B-8.5 B
Other Cashflows From Financing Activities-135.9 M-129.1 M
Total Cash From Operating Activities6.7 B8.6 B
Total Cash From Financing Activities-1.9 B-1.8 B
Other Cashflows From Investing Activities-146.1 M-138.7 M
End Period Cash Flow31.1 B23.8 B
Begin Period Cash Flow38.1 B23.2 B
Free Cash Flow-4 B-3.8 B
Other Non Cash Items-255.6 M-268.4 M

Currently Active Assets on Macroaxis

Other Information on Investing in Takara Stock

Takara Bio financial ratios help investors to determine whether Takara Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takara with respect to the benefits of owning Takara Bio security.